Home Fund Raises T3D Therapeutics, Inc. Form D

T3D Therapeutics, Inc.

Fund-raise round announced on 12 March 2018


T3D Therapeutics, Inc. planned to raise $18.00 M. So far, they have raised $ 6.00 M. The first sale took place on 02 March 2018. There was no minimum investment amount for this issue. 1 investors have participated in this issuance. The amount is being raised through the issue of Equity.

T3D Therapeutics, Inc., a Corporation incorporated in DELAWARE, filed a new Form D on 12 March 2018 announcing this fund raise. It listed its industry as Pharmaceuticals.

Date of filing: 12 March 2018
Type of filing: New
Offering size: 18,000,000 USD
Amount Raised: 6,000,000 USD
Type of security: Equity
Registration Exemptions: 06b

Issuer Profile

T3D Therapeutics, Inc. is a Corporation incorporated in the state of DELAWARE.

Central Index Key0001579600
Entity TypeCorporation
Incorporation Year More than 5 years ago
Address 68 TW Alexander Drive, None, Research Triangle Park, NC 27709
Phone Number919-949-0517
Previously Known As
Revenue RangeDecline To Disclose
Aggregate Net Asset Value RangeDecline To Disclose

Issuer's Personnel

The issuer has disclosed 5 executives, directors and promoters.

Name: John Didsbury
Designation: Executive Officer, Director, Promoter

Name: Charles Lineberry
Designation: Director

Name: Barry Buzogany
Designation: Director

Name: John Golden
Designation: Director

Name: Tom Mendell
Designation: Director